Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas
M Tanaka, C Fernández-del Castillo, T Kamisawa… - Pancreatology, 2017 - Elsevier
The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In
particular, the indications for resection of branch duct IPMN have changed from early …
particular, the indications for resection of branch duct IPMN have changed from early …
Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines
NCM Van Huijgevoort, M Del Chiaro… - Nature reviews …, 2019 - nature.com
Pancreatic cystic neoplasms (PCN) are a heterogeneous group of pancreatic cysts that
include intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, serous cystic …
include intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, serous cystic …
European evidence-based guidelines on pancreatic cystic neoplasms
European Study Group on Cystic Tumours of the … - Gut, 2018 - gut.bmj.com
Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are
lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of …
lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of …
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress
Traditionally viewed as poorly plastic, neutrophils are now recognized as functionally
diverse; however, the extent and determinants of neutrophil heterogeneity in humans remain …
diverse; however, the extent and determinants of neutrophil heterogeneity in humans remain …
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) …
M Goggins, KA Overbeek, R Brand, S Syngal… - Gut, 2020 - gut.bmj.com
Background and aim The International Cancer of the Pancreas Screening Consortium met in
2018 to update its consensus recommendations for the management of individuals with …
2018 to update its consensus recommendations for the management of individuals with …
Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study
ML Kromrey, R Bülow, J Hübner, C Paperlein… - Gut, 2018 - gut.bmj.com
Objective To analyse the prevalence, incidence and clinical relevance of pancreatic cysts
detected as incidental finding in a population-based longitudinal study. Design A total of …
detected as incidental finding in a population-based longitudinal study. Design A total of …
Recent trends in the incidence and survival of stage 1A pancreatic cancer: a surveillance, epidemiology, and end results analysis
Background Rapid access to pancreatic imaging and regular pancreatic surveillance may
help identify stage I pancreatic cancer. We investigated recent trends in the stage of newly …
help identify stage I pancreatic cancer. We investigated recent trends in the stage of newly …
A multimodality test to guide the management of patients with a pancreatic cyst
Pancreatic cysts are common and often pose a management dilemma, because some cysts
are precancerous, whereas others have little risk of develo** into invasive cancers. We …
are precancerous, whereas others have little risk of develo** into invasive cancers. We …
Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review
Background This systematic review aimed to assess the diagnostic accuracy of the
International Consensus Fukuoka Guidelines (ICG2017) in identifying high-risk lesions of …
International Consensus Fukuoka Guidelines (ICG2017) in identifying high-risk lesions of …
Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms
Abstract Background/Objectives: Intraductal papillary mucinous neoplasms (IPMNs) are a
cystic precursor to pancreatic cancer. IPMNs deemed clinically to be at high-risk for …
cystic precursor to pancreatic cancer. IPMNs deemed clinically to be at high-risk for …